The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989 · see citing works

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160 · see citing works

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239 · see citing works

Comprehensive molecular portraits of human breast tumours

The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129 · see citing works

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660 · see citing works

Molecular and genetic properties of tumors associated with local immune cytolytic activity

Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825 · see citing works

Genomic instability — an evolving hallmark of cancer

Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397 · see citing works

Landscape of somatic mutations in 560 breast cancer whole-genome sequences

Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., et al. (2016) · Nature · doi:10.1038/nature17676 · Cited by 2,218 · see citing works

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

Mateo, J., Carreira, S., Sandhu, S., Miranda, S., Mossop, H., Perez-Lopez, R., Nava Rodrigues, D., Robinson, D., Omlin, A., Tunariu, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506859 · Cited by 2,185 · see citing works

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

Cheng, D. T., Mitchell, T. N., Zehir, A., Shah, R. H., Benayed, R., Syed, A., Chandramohan, R., Liu, Z. Y., Won, H. H., Scott, S. N., et al. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.12.006 · Cited by 2,119 · see citing works

The ATM protein kinase: regulating the cellular response to genotoxic stress, and more

Shiloh, Y., & Ziv, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3546 · Cited by 1,649 · see citing works

Incidence of Cancer in 161 Families Affected by Ataxia–Telangiectasia

Swift, M., Morrell, D., Massey, R. B., & Chase, C. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112263252602 · Cited by 934 · see citing works

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer

Polak, P., Kim, J., Braunstein, L. Z., Karlic, R., Haradhavala, N. J., Tiao, G., Rosebrock, D., Livitz, D., Kübler, K., Mouw, K. W., et al. (2017) · Nature Genetics · doi:10.1038/ng.3934 · Cited by 531 · see citing works

Dominant Negative ATM Mutations in Breast Cancer Families

Chenevix‐Trench, G. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.3.205 · Cited by 376 · see citing works

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers

Maxwell, K. N., Wubbenhorst, B., Wenz, B. M., De Sloover, D., Pluta, J., Emery, L., Barrett, A., Kraya, A. A., Anastopoulos, I. N., Yu, S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00388-9 · Cited by 296 · see citing works

Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancer

Nolan, E., Savas, P. S., Policheni, A. N., Darcy, P. K., Vaillant, F., Mintoff, C., Dushyanthen, S., Mansour, M., Pang, J., Fox, S. B., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal4922 · Cited by 293 · see citing works

Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes

Riaz, N., Blecua, P., Lim, R. S., Shen, R., Higginson, D. S., Weinhold, N., Norton, L., Weigelt, B., Powell, S. N., & Reis-Filho, J. S. (2017) · Nature Communications · doi:10.1038/s41467-017-00921-w · Cited by 246 · see citing works

p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative toTP53 mutation

Pettitt, A. R., Sherrington, P. D., Stewart, G. S., Cawley, J. C., Taylor, A. M. R., & Stanković, T. (2001) · Blood · doi:10.1182/blood.v98.3.814 · Cited by 236 · see citing works

Rare variants in the ATMgene and risk of breast cancer

Goldgar, D. E., Healey, S. C., Dowty, J. G., Silva, L. M. D., Chen, X., Spurdle, A. B., Terry, M. B., Daly, M., Buys, S. M., Southey, M. C., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2919 · Cited by 227 · see citing works

CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer

Leiserson, M. D. M., Wu, H.-T., Vandin, F., & Raphael, B. J. (2015) · Genome biology · doi:10.1186/s13059-015-0700-7 · Cited by 202 · see citing works

Compromised BRCA1–PALB2 interaction is associated with breast cancer risk

Foo, T. K., Tischkowitz, M. D., Simhadri, S. R., Boshari, T., Zayed, N., Burke, K. A., Berman, S. H., Blecua, P., Riaz, N., Huo, Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.46 · Cited by 84 · see citing works

Proper genomic profiling of (BRCA1‐mutated) basal‐like breast carcinomas requires prior removal of tumor infiltrating lymphocytes

Massink, M. P. G., Kooi, I. E., van Mil, S. E., Jordanova, E. S., Ameziane, N., Dorsman, J. C., van Beek, D. M., van der Voorn, J. P., Sie, D., Ylstra, B., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.012 · Cited by 21 · see citing works

Pathogenesis of Triple-Negative Breast Cancer

Derakhshan, F., & Reis-Filho, J. S. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042420-093238 · Cited by 714 · see citing works

Non-BRCA DNA Damage Repair Gene Alterations and Response to the PARP Inhibitor Rucaparib in Metastatic Castration-Resistant Prostate Cancer: Analysis From the Phase II TRITON2 Study

Abida, W. M., Campbell, D. C., Patnaik, A., Shapiro, J. D., Sautois, B. R., Vogelzang, N. J., Voog, É., Bryce, A. H., McDermott, R., Ricci, F., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-0394 · Cited by 384 · see citing works

Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline

Tung, N., Boughey, J. C., Pierce, L. J., Robson, M. E., Bedrosian, I., Dietz, J. R., Dragun, A. J., Balmañà, J., Hofstatter, E. W., Isaacs, C. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00299 · Cited by 334 · see citing works

Synthetic Lethality in Cancer Therapeutics: The Next Generation

Setton, J. S., Zinda, M. J., Riaz, N., Durocher, D., Zimmermann, M., Koehler, M. T., Reis-Filho, J. S., & Powell, S. N. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1503 · Cited by 211 · see citing works

Advancing Personalized Medicine Through the Application of Whole Exome Sequencing and Big Data Analytics

Suwinski, P., Ong, C. K., Ling, M. H., Poh, Y. M., Khan, A. M., & Ong, H. S. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00049 · Cited by 213 · see citing works

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations

Marshall, C. H., Sokolova, A. O., McNatty, A. L., Cheng, H. H., Eisenberger, M. A., Bryce, A. H., Schweizer, M. T., & Antonarakis, E. S. (2019) · European Urology · doi:10.1016/j.eururo.2019.02.002 · Cited by 158 · see citing works

Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma

Golan, T., O'Kane, G. M., Denroche, R. E., Raitses‐Gurevich, M., Grant, R. C., Holter, S., Wang, Y., Zhang, A. X. W., Jang, G. H., Stossel, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.220 · Cited by 155 · see citing works

Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents

Póti, Á., Gyergyák, H., Németh, E., Rusz, O., Tóth, S., Kovácsházi, C., Chen, D., Szikriszt, B., Spisák, S., Takeda, S., et al. (2019) · Genome Biology · doi:10.1186/s13059-019-1867-0 · Cited by 116 · see citing works

Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases

da Silva, E. M., Fix, D. J., Sebastião, A. P. M., Selenica, P., Ferrando, L., Kim, S. H., Stylianou, A. A., Paula, A. D. C., Pareja, F. G., Smith, E. S., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00799-6 · Cited by 124 · see citing works

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

Yap, T. A., Fontana, E., Lee, E. K., Spigel, D. R., Højgaard, M., Lheureux, S., Mettu, N. B., Carneiro, B. A., Carter, L., Plummer, R., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02399-0 · Cited by 115 · see citing works

Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer

Lotan, T. L., Kaur, H. B., Salles, D. C., Murali, S., Schaeffer, E. M., Lanchbury, J. S. S., Isaacs, W. B., Brown, R. E., Richardson, A. L., Cussenot, O., et al. (2021) · Modern Pathology · doi:10.1038/s41379-020-00731-4 · Cited by 108 · see citing works

Targeting ATR in patients with cancer

Ngoi, N. Y. L., Pilie, P. G., McGrail, D. J., Zimmermann, M., Schlacher, K., & Yap, T. A. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00863-5 · Cited by 114 · see citing works

Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers

Nones, K., Johnson, J., Newell, F., Patch, A. M., Thorne, H., Kazakoff, S. H., de Luca, X. M., Parsons, M. T., Ferguson, K., Reid, L. E., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz132 · Cited by 93 · see citing works

Molecular profiling and molecular classification of endometrioid ovarian carcinomas

Cybulska, P., Paula, A. D. C., Tseng, J. H., Leitão, M. M., Bashashati, A., Huntsman, D. D., Nazeran, T. M., Aghajanian, C. A., Abu‐Rustum, N. R., DeLair, D. F., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.07.012 · Cited by 101 · see citing works

Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer

Kraya, A., Maxwell, K. N., Wubbenhorst, B. S., Wenz, B. M., Pluta, J. B., Rech, A. J., Dorfman, L. M., Lunceford, N., Barrett, A., Mitra, N., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0468 · Cited by 101 · see citing works

Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression

Ashley, C. W., Paula, A. D. C., Kumar, R., Mandelker, D. L., Pei, X., Riaz, N., Reis-Filho, J. S., & Weigelt, B. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.10.032 · Cited by 94 · see citing works

BRCA2 , ATM , and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression

Warner, E. W., Herberts, C., Fu, S. Y. F., Yip, S., Wong, A., Wang, G., Ritch, E. J., Murtha, A. J., Vandekerkhove, G. R., Fonseca, N. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3708 · Cited by 88 · see citing works

Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer —Association With Patient and Disease Characteristics and Effect on Prognosis

Fasching, P. A., Yadav, S., Hu, C., Wunderle, M., Häberle, L., Hart, S. N., Rübner, M., Polley, E. C., Lee, K. Y., Gnanaolivu, R. D., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01200 · Cited by 84 · see citing works

Hereditary breast cancer: syndromes, tumour pathology and molecular testing

Sokolova, A., Johnstone, K. J., Reed, A. E. M., Simpson, P. T., & Lakhani, S. R. (2022) · Histopathology · doi:10.1111/his.14808 · Cited by 86 · see citing works

Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX

Sehdev, A., Gbolahan, O. B., Hancock, B. A., Stanley, M., Shahda, S., Wan, J., Wu, H. H., Radovich, M., & O’Neil, B. H. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1472 · Cited by 80 · see citing works

Whole-Exome Sequencing Analysis of the Progression from Non–Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma

Pareja, F. G., Brown, D. N., Lee, J. Y., Paula, A. D. C., Selenica, P., Bi, R., Geyer, F. C., Gazzo, A. M., da Silva, E. M., Vahdatinia, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2563 · Cited by 79 · see citing works

ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications

Armstrong, S. A., Schultz, C. W., Azimi-Sadjadi, A., Brody, J. R., & Pishvaian, M. J. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0208 · Cited by 74 · see citing works

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy

Pitter, K. L., Casey, D. L., Lu, Y. C., Hannum, M., Zhang, Z., Song, X., Pecorari, I. L., McMillan, B., Ma, J., Samstein, R. M., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa095 · Cited by 69 · see citing works

Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary

Paula, A. D. C., da Silva, E. M., Segura, S. E., Pareja, F. G., Bi, R., Selenica, P., Kim, S. H., Ferrando, L., Vahdatinia, M., Soslow, R. A., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-0514-3 · Cited by 64 · see citing works

Germline Genetic Testing for Breast Cancer Risk: The Past, Present, and Future

Yadav, S., & Couch, F. J. (2019) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_238987 · Cited by 61 · see citing works

Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma

Lee, J. Y., Schizas, M., Geyer, F. C., Selenica, P., Piscuoglio, S., Sakr, R. A., Ng, C. K. Y., Carniello, J. V. S., Towers, R., Giri, D. D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1103 · Cited by 60 · see citing works

Homologous recombination DNA repair defects in PALB2-associated breast cancers

Li, A., Geyer, F. C., Blecua, P., Lee, J. Y., Selenica, P., Brown, D. N., Pareja, F. G., Lee, S., Kumar, R., Rivera, B., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0115-9 · Cited by 56 · see citing works

Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation

Selenica, P., Conlon, N., Gonzalez, C., Frosina, D., Jungbluth, A. A., Beets‐Tan, R. G. H., Rao, M., Zhang, Y., Benayed, R., Ladanyi, M., et al. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001572 · Cited by 56 · see citing works

APOBEC mutagenesis, kataegis, chromothripsis in EGFR-mutant osimertinib-resistant lung adenocarcinomas

Selenica, P., Marra, A., Choudhury, N. J., Gazzo, A. M., Falcon, C. J., Patel, J., Pei, X., Zhu, Y., Ng, C. K. Y., Curry, M., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.09.151 · Cited by 49 · see citing works

BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer

Liu, Y. L., Selenica, P., Zhou, Q. C., Iasonos, A. E., Callahan, M. K., Feit, N. Z., Boland, J. L., Vázquez-Garćıa, I., Mandelker, D. L., Zehir, A., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00069 · Cited by 48 · see citing works

The genomic landscape of metastatic histologic special types of invasive breast cancer

Pareja, F. G., Ferrando, L., Lee, S., de Beça, F. F., Selenica, P., Brown, D. N., Farmanbar, A., Paula, A. D. C., Vahdatinia, M., Zhang, H., et al. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-00195-4 · Cited by 46 · see citing works

Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway

Selenica, P., Raj, N. P., Kumar, R., Brown, D. N., Arqués, O., Reidy‐Lagunes, D. L., Klimstra, D. S., Snuderl, M., Serrano, J., Pálmer, H. G., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12490 · Cited by 46 · see citing works

Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes

Moukarzel, L. A., Paula, A. D. C., Ferrando, L., Hoang, T. J., Sebastião, A. P. M., Pareja, F. G., Park, K. J., Jungbluth, A. A., Capellá, G., Pineda, M., et al. (2020) · Modern Pathology · doi:10.1038/s41379-020-00721-6 · Cited by 47 · see citing works

Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma

Yadav, S., Kasi, P. M., Bamlet, W. R., Ho, T. P., Polley, E. C., Hu, C., Hart, S. N., Rabe, K. G., Boddicker, N. J., Gnanaolivu, R. D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1788 · Cited by 43 · see citing works

Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma Risk

Selvan, M. E., Zauderer, M. G., Rudin, C. M., Jones, S., Mukherjee, S., Offit, K., Onel, K., Rennert, G., Velculescu, V. E., Lipkin, S. M., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.08.017 · Cited by 38 · see citing works

The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers

Mandelker, D. L., Kumar, R., Pei, X., Selenica, P., Setton, J. S., Arunachalam, S., Ceyhan‐Birsoy, O., Brown, D. N., Norton, L., Robson, M. E., et al. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz027 · Cited by 36 · see citing works

A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability

Fagan‐Solis, K. D., Simpson, D. A., Kumar, R. J., Martelotto, L. G., Mose, L. E., Rashid, N. U., Ho, A. Y., Powell, S. N., Wen, Y., Parker, J. S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.020 · Cited by 36 · see citing works

Clinico-genomic Characterization of <i>ATM</i> and HRD in Pancreas Cancer: Application for Practice

Park, W., O'Connor, C. A., Bandlamudi, C., Forman, D., Chou, J. F., Umeda, S., Reyngold, M., Varghese, A. M., Keane, F., Balogun, F., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1483 · Cited by 34 · see citing works

Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer

Li, N., McInerny, S., Zethoven, M., Cheasley, D. A., Lim, B. W. X., Rowley, S. M., Devereux, L., Grewal, N., Ahmadloo, S., Byrne, D. J., et al. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz045 · Cited by 34 · see citing works

Homologous recombination deficiency: how genomic signatures are generated

Setton, J. S., Reis-Filho, J. S., & Powell, S. N. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.01.002 · Cited by 33 · see citing works

DNA Repair Deficiency in Breast Cancer: Opportunities for Immunotherapy

Gilmore, E. S., McCabe, N., Kennedy, R. D., & Parkes, E. E. (2019) · Journal of Oncology · doi:10.1155/2019/4325105 · Cited by 31 · see citing works

Clinical patterns and genomic profiling of recurrent ‘ultra-low risk’ endometrial cancer

Stasenko, M., Feit, N. Z., Lee, S., Shepherd, C., Soslow, R. A., Cadoo, K. A., Alektiar, K. M., da Silva, E. M., Sebastião, A. P. M., Leitão, M. M., et al. (2020) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2020-001241 · Cited by 32 · see citing works

TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer

da Silva, E. M., Selenica, P., Vahdatinia, M., Pareja, F. G., Paula, A. D. C., Ferrando, L., Gazzo, A. M., Dopeso, H., Ross, D. S., Bakhteri, A., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00250-8 · Cited by 31 · see citing works

Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression

Mota, A., Oltra, S. S., Selenica, P., Moiola, C. P., Casas‐Arozamena, C., López-Gil, C., Díaz, E., Gatius, S., Ruiz-Miró, M., Calvo, A., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02221-0 · Cited by 30 · see citing works

Genomic Alterations as Potential Therapeutic Targets in Extramammary Paget’s Disease of the Vulva

Stasenko, M., Jayakumaran, G., Cowan, R. A., Broach, V. A., Dennis, S., Rossi, A., Hollman, T. J., Zehir, A., Abu‐Rustum, N. R., & Leitão, M. M. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00073 · Cited by 29 · see citing works

Dilemma of Reporting Incidental Findings in Newborn Screening Programs for SCID: Parents’ Perspective on Ataxia Telangiectasia

Blom, M., Schoenaker, M. H. D., Hulst, M., de Vries, M. C., Weemaes, C. M. R., Willemsen, M. A. A. P., Henneman, L., & van der Burg, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02438 · Cited by 26 · see citing works

Massively parallel sequencing analysis of benign melanocytic naevi

Lozada, J. R., Geyer, F. C., Selenica, P., Brown, D. N., Alemar, B., Merghoub, T., Berger, M. F., BUSAM, K. J., Halpern, A. C., Weigelt, B., et al. (2019) · Histopathology · doi:10.1111/his.13843 · Cited by 27 · see citing works

Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

Liu, Y. L., Cadoo, K. A., Mukherjee, S., Khurram, A., Tkachuk, K., Kemel, Y. M., Maio, A., Belhadj, S., Carlo, M. I., Latham, A. J., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0820 · Cited by 23 · see citing works

Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer

Weigelt, B., Vargas, H. A., Selenica, P., Geyer, F. C., Mazaheri, Y., Blecua, P., Conlon, N., Hoang, L. N., Jungbluth, A. A., Snyder, A., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00410 · Cited by 23 · see citing works

Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer

Kutasovic, J. R., Reed, A. E. M., Sokolova, A., Lakhani, S. R., & Simpson, P. T. (2020) · Cancers · doi:10.3390/cancers12040848 · Cited by 23 · see citing works

Converging and evolving immuno-genomic routes toward immune escape in breast cancer

Blanco-Heredia, J., Souza, C. A., Trincado, J. L., González‐Cao, M., Gonçalves-Ribeiro, S., Gil, S. R., Pravdyvets, D., Cedeño, S., Callari, M., Marra, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45292-1 · Cited by 22 · see citing works

Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

Pal, T., Schon, K. R., Astiazarán-Symonds, E., Balmañà, J., Foulkes, W. D., James, P. A., Klugman, S. D., Livinski, A. A., Mak, J. S., Ngeow, J. Y. Y., et al. (2024) · Genetics in Medicine · doi:10.1016/j.gim.2024.101243 · Cited by 21 · see citing works

First international workshop of the ATM and cancer risk group (4-5 December 2019)

Lesueur, F., Easton, D. F., Renault, A., Tavtigian, S. V., Bernstein, J. L., Kote‐Jarai, Z., Eeles, R. A., Plaseska-Karanfia, D., Feliubadaló, L., Spanish ATM working group, et al. (2021) · Familial Cancer · doi:10.1007/s10689-021-00248-y · Cited by 21 · see citing works

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study

Li, N., Lim, B. W. X., Thompson, E. R., McInerny, S., Zethoven, M., Cheasley, D. A., Rowley, S. M., Wong‐Brown, M. W., Devereux, L., Gorringe, K. L., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00279-9 · Cited by 21 · see citing works

NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift

Richardson, E. T., Selenica, P., Pareja, F. G., Cin, P. D., Hanlon, E., Weigelt, B., Reis-Filho, J. S., Hornick, J. L., Jo, V. Y., & Schnitt, S. J. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100144 · Cited by 21 · see citing works

Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management

McGee, R. B., Oak, N., Harrison, L. H., Xu, K., Nuccio, R., Blake, A. K., Mostafavi, R. M., Lewis, S., Taylor, L. M., Kubal, M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2482 · Cited by 20 · see citing works

Landscape of somatic mutations in breast cancer: new opportunities for targeted therapies in Saudi Arabian patients

Barakeh, D. H., Aljelaify, R. F., Bashawri, Y., Almutairi, A., Alqubaishi, F., Alnamnakani, M., AlMubarak, L., Naeem, A. A., AlMushawah, F., Alrashed, M. M., et al. (2021) · Oncotarget · doi:10.18632/oncotarget.27909 · Cited by 19 · see citing works

Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types

Pilie, P. G., Giuliani, V., Wang, W., McGrail, D. J., Bristow, C. A., Ngoi, N. Y. L., Kyewalabye, K., Wani, K., Le, H., Campbell, E., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1763 · Cited by 19 · see citing works

Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites

Pareja, F. G., Vahdatinia, M., Marchiò, C., Lee, S., Paula, A. D. C., Derakhshan, F. N., da Silva, E. M., Selenica, P., Dopeso, H., Chandarlapaty, S., et al. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-207052 · Cited by 18 · see citing works

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Kahn, R. M., Selenica, P., Boerner, T., Roche, K. L., Xiao, Y., Sia, T., Maio, A., Kemel, Y. M., Sheehan, M. R., Salo‐Mullen, E. E., et al. (2023) · Gynecologic Oncology · doi:10.1016/j.ygyno.2023.11.019 · Cited by 18 · see citing works

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies

Radosevic‐Robin, N., Selenica, P., Zhu, Y., Won, H. H., Berger, M. F., Ferrando, L., Cocco, E., Privat, M., Ponelle‐Chachuat, F., Abrial, C., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00334-5 · Cited by 17 · see citing works

New Therapeutic Options for BRCA Mutant Patients

Ghanem, A., & Domchek, S. M. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-082523-083843 · Cited by 17 · see citing works

To indel or not to indel: Factors influencing mutagenesis during chromosomal break end joining

Cisneros‐Aguirre, M., Ping, X., & Stark, J. M. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103380 · Cited by 17 · see citing works

Sclerosing epithelioid mesenchymal neoplasm of the pancreas – a proposed new entity

Baştürk, O., Weigelt, B., Adsay, V. N., Benhamida, J. K., Aşkan, G., Wang, L., Arcila, M. E., Zamboni, G., Fukushima, N., Gularte‐Mérida, R., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0334-5 · Cited by 15 · see citing works

A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer

Veeraraghavan, J., Gutiérrez, C., Angelis, C. D., Davis, R., Wang, T., Pascual, T., Selenica, P., Sanchez, K., Nitta, H., Kapadia, M. J., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3753 · Cited by 14 · see citing works

Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient

Meijer, T. G., Martens, J. W. M., der Smissen, W. J. C. P., Verkaik, N. S., Beaufort, C. M., van Herk, S., Robert-Finestra, T., Hoogenboezem, R. M., Ruigrok-Ritstier, K., Paul, M. W., et al. (2024) · Cancers · doi:10.3390/cancers16040741 · Cited by 13 · see citing works

Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer

Liu, Y., Zou, Y., Ye, Y., & Chen, Y. (2024) · Cancer Medicine · doi:10.1002/cam4.70410 · Cited by 13 · see citing works

Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants

Lim, B. W. X., Li, N., Mahale, S., McInerny, S., Zethoven, M., Rowley, S. M., Huynh, J., Wang, T., Lee, J. E. A., Friedman, M., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac196 · Cited by 13 · see citing works

Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women

Filippova, O. T., Selenica, P., Pareja, F. G., Vahdatinia, M., Zhu, Y., Pei, X., Riaz, N., Roche, K. L., Dennis, S., Abu‐Rustum, N. R., et al. (2021) · Gynecologic Oncology · doi:10.1016/j.ygyno.2021.02.028 · Cited by 13 · see citing works

The utility of homologous recombination deficiency biomarkers across cancer typesPreprint

Takamatsu, S., Brown, J. B., Yamaguchi, K. D., Hamanishi, J., Yamanoi, K., Takaya, H., Kaneyasu, T., Mori, S., Mandai, M., & Matsumura, N. (2021) · medRxiv · doi:10.1101/2021.02.18.21251882 · Cited by 13 · see citing works

ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications

Jabbour, T. E., Misyura, M., Cowzer, D., Zimmermann, M., Rimkunas, V. M., Marra, A., Derakhshan, F. N., Selenica, P., Parilla, M., Setton, J. S., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac024 · Cited by 12 · see citing works

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

Safonov, A. M., Lee, M. K., Brown, D. N., Bielo, L. B., Mehine, M. M., Bandlamudi, C., O’Leary, B., Shao, H., Vicente, L., Muldoon, D. M., et al. (2026) · Nature · doi:10.1038/s41586-026-10197-0 · Cited by 13 · see citing works

Risk Stratification of Stage I Grade 3 Endometrioid Endometrial Carcinoma in the Era of Molecular Classification

Zammarrelli, W. A., Kim, S. H., Paula, A. D. C., Rios‐Doria, E., Ehmann, S., Yeoshoua, E., Hanlon, E., Zhou, Q. C., Iasonos, A. E., Alektiar, K. M., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.22.00194 · Cited by 11 · see citing works

Analysis, identification and visualization of subgroups in genomics

Völkel, G., Laban, S. A., Fürstberger, A., Werle, S. D., Ikonomi, N., Hoffmann, T. K., Brunner, C., Neuberg, D. S., Gaidzik, V. I., Döhner, H., et al. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa217 · Cited by 11 · see citing works

Performance of a RAD51-based functional HRD test on paraffin-embedded breast cancer tissue

van Wijk, L. M., Vermeulen, S., ter Haar, N. T., Kramer, C. J. H., Terlouw, D., Vrieling, H., Cohen, D., & Vreeswijk, M. P. G. (2023) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07102-y · Cited by 10 · see citing works

Nonrepair functions of DNA mismatch repair proteins: new avenues for precision oncology

DeWitt, J. T., Raghunathan, M., & Haricharan, S. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.10.001 · Cited by 10 · see citing works

Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer

Grochot, R. M., Carreira, S., Miranda, S., Figueiredo, I., Bertan, C. M., Rekowski, J., Yuan, W., Ferreira, A., Riisnaes, R., Neeb, A., et al. (2023) · European Urology Open Science · doi:10.1016/j.euros.2023.04.003 · Cited by 10 · see citing works

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile

Smid, M., Schmidt, M. K., der Smissen, W. J. C. P., Ruigrok-Ritstier, K., Schreurs, M. A. C., Cornelissen, S., Garcia, A. M., Broeks, A., Timmermans, A. M., Trapman-Jansen, A., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01653-0 · Cited by 10 · see citing works

The cold immunological landscape of ATM-deficient cancers

Sinha, S., Ng, V., Novaj, A., Zhu, Y., Yazaki, S., Pei, X., Derakhshan, F. N., Pareja, F. G., Setton, J. S., Naulin, F., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010548 · Cited by 8 · see citing works

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.

Davidson, A. L., Michailidou, K., Parsons, M., Fortuno, C., Bolla, M., Wang, Q., Dennis, J., Naven, M., Abubakar, M., Ahearn, T., et al. (2024) · American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.07.004 · Cited by 7 · see citing works

PARP inhibition in prostate cancer

Nientiedt, C., Duensing, A. U., Zschäbitz, S., Jäger, D., Hohenfellner, M., Stenzinger, A., & Duensing, S. M. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22903 · Cited by 8 · see citing works

Whole‐exome sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma

D’Alfonso, T. M., Pareja, F. G., Paula, A. D. C., Vahdatinia, M., Gazzo, A. M., Ferrando, L., da Silva, E. M., Cheng, E., Sclafani, L. M., Chandarlapaty, S., et al. (2020) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.190 · Cited by 8 · see citing works

Techniques for Profiling the Cellular Immune Response and Their Implications for Interventional Oncology

Garg, T., Weiss, C. R., & Sheth, R. A. (2022) · Cancers · doi:10.3390/cancers14153628 · Cited by 7 · see citing works

Molecular Basis of Breast Tumor Heterogeneity

Dikoglu, E., & Pareja, F. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-70875-6_13 · Cited by 6 · see citing works

Extended gene panel testing in lobular breast cancer

van Veen, E. M., Evans, D. G., Harkness, E. F., Byers, H., Ellingford, J. M., Woodward, E. R., Bowers, N. L., Wallace, A. J., Howell, S. J., Howell, A., et al. (2021) · Familial Cancer · doi:10.1007/s10689-021-00241-5 · Cited by 6 · see citing works

Next Generation Sequencing

Prasad, A., Bhargava, H., Gupta, A., Shukla, N., Rajagopal, S. P., Gupta, S., Sharma, A., Valadi, J. K., Nigam, V. K., & Suravajhala, P. (2021) · Springer eBooks · doi:10.1007/978-981-33-6191-1_14 · Cited by 6 · see citing works

Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma

Ashley, C. W., Paula, A. D. C., Ferrando, L., Gularte‐Mérida, R., Sebastião, A. P. M., Brown, D. N., Gazzo, A. M., Pareja, F. G., Stylianou, A. A., Abu‐Rustum, N. R., et al. (2021) · Histopathology · doi:10.1111/his.14346 · Cited by 6 · see citing works

Ataxia telangiectasia mutated (ATM) kinase as a predictive biomarker in clinical oncology: implications for a precision treatment approach

Pham, A. T., Yuan, F., Nagathihalli, N. S., & Dosch, A. R. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101309 · Cited by 5 · see citing works

Biological and genetic basis of various human genetic disorders and the application of biological and genetic markers

Oyouni, A. A. A. (2022) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2022.101961 · Cited by 5 · see citing works

Genomic landscape of breast cancer in elderly patients

Selenica, P., Dopeso, H., Repetto, M., Basili, T., Gazzo, A. M., Schwartz, C. J., Derakhshan, F. N., Marra, A., Ferrando, L., Beets‐Tan, R. G. H., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00781-4 · Cited by 5 · see citing works

Uncovering variable neoplasms between ATM protein‐truncating and common missense variants using 394 694 UK Biobank exomes

Jiang, X., O'Neill, A., Smith, K. R., Lai, Z., Carss, K., Wang, Q., & Petrovski, S. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23042 · Cited by 4 · see citing works

Molecular diagnosis in breast cancer

Pareja, F. G., Marchiò, C., & Reis-Filho, J. S. (2018) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2018.01.001 · Cited by 4 · see citing works

Artificial Intelligence and Machine Learning Techniques Using Omics Data for Cancer Diagnosis and Treatment

Gawade, P., Nandi, S., Meena, C., & Sarkar, R. R. (2022) · Springer eBooks · doi:10.1007/978-981-19-1953-4_2 · Cited by 3 · see citing works

Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan‐cancer analysis

Sun, Z., Bai, C., Su, M., Tang, H., Wu, X., Wang, Y., Bao, H., Liu, X., Wu, X., Shao, Y., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13430 · Cited by 3 · see citing works

Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer

Cursano, M. C., Giunta, E. F., Scarpi, E., Casadei, C., Virga, A., Ulivi, P., Bleve, S., Brighi, N., Ravaglia, G., Pantano, F., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512436 · Cited by 3 · see citing works

Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing

Subramanian, D., Zethoven, M., Pishas, K. I., Marinović, E. R., McInerny, S., Rowley, S. M., Allan, P. E., Devereux, L., Cheasley, D. A., James, P. A., et al. (2025) · npj Genomic Medicine · doi:10.1038/s41525-024-00447-3 · Cited by 3 · see citing works

Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile

Viart, N. M., Renault, A., Eon, S., Jiao, Y., Fuhrmann, L., Houdigui, S. M. E., Gal, D. L., Cavaciuti, E., Dondon, M., Beauvallet, J., et al. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-01988-w · Cited by 3 · see citing works

ATM kinase regulates tumor immunoreactions in lymphocyte-predominant breast cancer through modulation of NKG2D ligand and TNF cytokines on tumor cells

Xu, P., Sun, Y., Song, Y., Jiao, J., Shen, B., Li, W., Jiang, C., Li, Y., Zhang, X., Yu, J., et al. (2020) · Medical Molecular Morphology · doi:10.1007/s00795-020-00247-5 · Cited by 3 · see citing works

AlphaMissense for Identifying Pathogenic Missense Mutations in DNA Damage Repair Genes in Cancer

Yazaki, S., Pei, X., Powell, S. N., Khan, A. J., Setton, J. S., & Riaz, N. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00908 · Cited by 4 · see citing works

Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis

Gatz, S. A., Bender, J. G., Pearson, A. D. J., Ortiz, M. V., Bernardi, R. J., Chesler, L., Clifford, S., Cohen‐Gogo, S., Cuesta, E. A. D. L., de Rojas, T., et al. (2026) · JCO Precision Oncology · doi:10.1200/po-25-00642 · Cited by 2 · see citing works

Abstract PD1-15: The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers

Weigelt, B., Bi, R., Kumar, R., James, P., Thorne, H., Couch, F., Eccles, D., Blows, F. M., Geyer, F., Li, A., et al. (2018) · Cancer Research · doi:10.1158/1538-7445.sabcs17-pd1-15

Analysis of Turkish Breast Cancer Patients With ATM-Heterozygous Germline Mutation According to Clinicopathological Features

Ünsal, O., Güvercin, B., Özet, A., & Ergün, M. A. (2023) · Cureus · doi:10.7759/cureus.47324 · Cited by 2 · see citing works

Histopathological features of breast cancer in carriers of ATM gene variants

Balleine, R. L., Murali, R., Bilous, A. M., Farshid, G., Waring, P., Provan, P. J., Byth, K., Thorne, H., kConFab Investigators, & Kirk, J. A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02538.x · Cited by 20 · see citing works

ATM-Heterozygous Germline Mutations Contribute to Breast Cancer–Susceptibility

Broeks, A., Urbanus, J. H. M., Floore, A. N., Dahler, E. C., Klijn, J. G. M., Rutgers, E. J. T., Devilee, P., Russell, N. S., van Leeuwen, F. E., & van't Veer, L. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302746 · Cited by 240 · see citing works

Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers

CoF-AT, Renault, A., GENESIS, kConFab, Mebirouk, N., Fuhrmann, L., Bataillon, G., Cavaciuti, E., Gal, D. L., Girard, E., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0951-9 · Cited by 45 · see citing works